Gain in growth after surgical repair of congenital heart disease among children with Down syndrome

Saquib, Nazmus; Sarraj, Anas Naser Al; Oubaied, Baraa Tarek Ziad; Rajab, Ahmad Mamoun; Agha, Bana Nasser; Hossain, Jesmin; Almazrou, Abdulrahman; Saquib, Juliann

doi:10.1002/ajmg.a.62483

Cited by 1 publication

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 19 The gain of growth was observed in children who underwent cardiac surgery/intervention. 31 Concomitant with this data, we found that weight and height SD were improved significantly 1 year after surgery ( Table 4 ).…”

Section: Discussionsupporting

confidence: 65%

Congenital Heart Defects and Outcome in a Large Cohort of Down Syndrome: A Single-Center Experience from Turkey

Alkaya¹,

Öztürk²,

Ülker³

et al. 2023

Turk Arch Pediatrics

View full text Add to dashboard Cite

Objective: Congenital heart defects occur in approximately 50% of children with Down syndrome and they contribute considerably to morbidity and mortality. The aim of this study is to investigate the prevalence, classification, and survival of congenital heart defects in Down syndrome. Materials and Methods: About 1731 Down syndrome patients who underwent echocardiography between 1986 and 2022 were evaluated. The median follow-up duration was 8.7 years (range 1-35.8 years). Congenital heart defect was grouped as cyanotic and acyanotic. Results : Among the 1731 patients, 52.1% had congenital heart defects. Congenital heart defect was significantly more common in females than males. The most common cardiac defect was ventricular septal defect (35%), followed by atrial septal defect (31.8%), atrioventricular septal defect (23.4%), tetralogy of Fallot (5%), and patent ductus arteriosus (3.6%). In the follow-up, 43.2% of atrial septal defect, 17.8% of ventricular septal defect, and a total of 20% of congenital heart defects were closed spontaneously. About 34.4% of congenital heart defect was corrected by cardiac surgery/intervention. Five-year survival rate was 97.4% in patients without congenital heart defects, whereas it was 95.6% in mild congenital heart defects and 86.1% in moderate to severe congenital heart defects. There was no relationship between consanguinity, parental age, maternal disease, folic acid supplementation before/during pregnancy, gestational age, birth weight, and congenital heart defects. Neuromotor development was similar in patients with and without congenital heart defects. Conclusion: We demonstrated that almost half of the patients had congenital heart defects; ventricular septal defect was the most common congenital heart defect type. This study is valuable in terms of the largest single-center study describing the classification, prognostic factors, and survival of Down syndrome patients with congenital heart defect from Turkey.

show abstract

Section: Discussionsupporting

confidence: 65%